These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23059185)
1. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Márquez MF; Bonny A; Hernández-Castillo E; De Sisti A; Gómez-Flores J; Nava S; Hidden-Lucet F; Iturralde P; Cárdenas M; Tonet J Heart Rhythm; 2012 Dec; 9(12):1995-2000. PubMed ID: 23059185 [TBL] [Abstract][Full Text] [Related]
2. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139 [TBL] [Abstract][Full Text] [Related]
3. Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF). Leshem E; Rahkovich M; Mazo A; Suleiman M; Blich M; Laish-Farkash A; Konstantino Y; Fogelman R; Strasberg B; Geist M; Chetboun I; Swissa M; Ilan M; Glick A; Michowitz Y; Rosso R; Glikson M; Belhassen B Isr Med Assoc J; 2018 May; 20(5):269-276. PubMed ID: 29761670 [TBL] [Abstract][Full Text] [Related]
4. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope. Márquez MF; Rivera J; Hermosillo AG; Iturralde P; Colín L; Moragrega JL; Cárdenas M Pacing Clin Electrophysiol; 2005 Aug; 28(8):870-3. PubMed ID: 16105018 [TBL] [Abstract][Full Text] [Related]
5. Low-Dose Quinidine Effectively Reduced Shocks in Brugada Syndrome Patients with an Implantable Cardioverter Defibrillator: A Chinese Case Series Report. Shen T; Yuan B; Geng J; Chen C; Zhou X; Shan Q Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27550400 [TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005 [TBL] [Abstract][Full Text] [Related]
8. Hydroquinidine therapy in Brugada syndrome. Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111 [TBL] [Abstract][Full Text] [Related]
9. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram. Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of quinidine in high-risk patients with Brugada syndrome. Belhassen B; Glick A; Viskin S Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640 [TBL] [Abstract][Full Text] [Related]
11. Electrical storm in patients with brugada syndrome is associated with early repolarization. Kaneko Y; Horie M; Niwano S; Kusano KF; Takatsuki S; Kurita T; Mitsuhashi T; Nakajima T; Irie T; Hasegawa K; Noda T; Kamakura S; Aizawa Y; Yasuoka R; Torigoe K; Suzuki H; Ohe T; Shimizu A; Fukuda K; Kurabayashi M; Aizawa Y Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1122-8. PubMed ID: 25221333 [TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment. Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076 [TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan. Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K; Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome. Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668 [TBL] [Abstract][Full Text] [Related]